Archive: 12/09/2021

Patients with malignant pleural mesothelioma face barriers to treatment access

A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found significant variability in access to care and a positive association between multimodality treatment, income levels, and survival ...

Sep 12, 2021

Neoadjuvant cisplatin, pemetrexed plus atezolizumab followed by surgical resection, maintenance atezolizumab is safe

Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural Mesothelioma at the ...

Sep 12, 2021